12,197 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by FORA Capital LLC

FORA Capital LLC acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 12,197 shares of the company's stock, valued at approximately $484,000.

Other institutional investors have also recently made changes to their positions in the company. Treasurer of the State of North Carolina increased its position in Acadia Healthcare by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after acquiring an additional 250 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares during the period. Coldstream Capital Management Inc. lifted its stake in Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after purchasing an additional 303 shares during the last quarter. Covestor Ltd boosted its position in shares of Acadia Healthcare by 27.2% during the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the period. Finally, Pacer Advisors Inc. grew its stake in shares of Acadia Healthcare by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock valued at $549,000 after buying an additional 325 shares during the last quarter.

Acadia Healthcare Stock Up 4.3%

Shares of ACHC traded up $1.10 during midday trading on Tuesday, hitting $26.94. 9,007,440 shares of the company's stock traded hands, compared to its average volume of 1,685,958. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The firm's fifty day moving average is $26.49 and its 200-day moving average is $36.14. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $2.48 billion, a price-to-earnings ratio of 8.83, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. During the same quarter last year, the company earned $0.84 earnings per share. The company's quarterly revenue was up .3% on a year-over-year basis. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ACHC. Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Guggenheim started coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $43.00 to $35.00 in a report on Friday, February 28th. KeyCorp dropped their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research note on Monday, March 3rd. Finally, Mizuho reduced their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $50.39.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.